- Home
- DAWN vs POM Comparison
DAWN vs POM Comparison
Compare DAWN & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- POM
- Stock Information
- Founded
- DAWN 2018
- POM 2015
- Country
- DAWN United States
- POM China
- Employees
- DAWN N/A
- POM N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- POM Other Specialty Stores
- Sector
- DAWN Health Care
- POM Consumer Discretionary
- Exchange
- DAWN Nasdaq
- POM Nasdaq
- Market Cap
- DAWN 624.8M
- POM 556.7M
- IPO Year
- DAWN 2021
- POM 2025
- Fundamental
- Price
- DAWN $7.47
- POM $4.41
- Analyst Decision
- DAWN Strong Buy
- POM
- Analyst Count
- DAWN 7
- POM 0
- Target Price
- DAWN $27.86
- POM N/A
- AVG Volume (30 Days)
- DAWN 1.5M
- POM 3.8M
- Earning Date
- DAWN 10-30-2025
- POM 01-01-0001
- Dividend Yield
- DAWN N/A
- POM N/A
- EPS Growth
- DAWN N/A
- POM N/A
- EPS
- DAWN N/A
- POM N/A
- Revenue
- DAWN $187,638,000.00
- POM $46,931,528.00
- Revenue This Year
- DAWN $12.96
- POM N/A
- Revenue Next Year
- DAWN $48.40
- POM N/A
- P/E Ratio
- DAWN N/A
- POM N/A
- Revenue Growth
- DAWN 2190.50
- POM 12.37
- 52 Week Low
- DAWN $5.64
- POM $3.47
- 52 Week High
- DAWN $16.76
- POM $5.04
- Technical
- Relative Strength Index (RSI)
- DAWN 53.82
- POM N/A
- Support Level
- DAWN $6.99
- POM N/A
- Resistance Level
- DAWN $7.73
- POM N/A
- Average True Range (ATR)
- DAWN 0.44
- POM 0.00
- MACD
- DAWN 0.02
- POM 0.00
- Stochastic Oscillator
- DAWN 48.73
- POM 0.00
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.